Market Summary

Global Mice Model Market size and share is currently valued at USD 1.36 billion in 2023 and is anticipated to generate an estimated revenue of USD 2.68 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.8% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032

The mice model market is experiencing significant growth, driven by increasing research and development activities in biomedical, pharmaceutical, and genetic studies. Mice models, which include genetically modified, inbred, and transgenic mice, are extensively used in preclinical testing, drug discovery, and disease research due to their genetic similarity to humans and reproducible biological responses. These models provide essential insights into human diseases, enabling researchers to develop effective treatments, therapies, and vaccines.

With the rise of chronic diseases, cancer, neurological disorders, and infectious diseases, the demand for specialized mice models has grown substantially. Advanced technologies in genetic engineering, such as CRISPR and knockout models, have further enhanced the utility of mice in research. Academic institutions, pharmaceutical companies, and biotechnology firms increasingly rely on mice models to accelerate scientific discovery, reduce experimental timelines, and improve the accuracy of preclinical studies.

Key Market Growth Drivers

1. Rising demand for drug discovery and development – Pharmaceutical and biotech companies use mice models extensively to evaluate the safety and efficacy of new drugs before clinical trials.
2. Advancements in genetic engineering – CRISPR, transgenic, and knockout technologies enable the creation of disease-specific models, improving research precision and reproducibility.
3. Increasing prevalence of chronic and lifestyle diseases – The global burden of diseases such as diabetes, cancer, and neurological disorders fuels research using mice models to develop novel therapies.
4. Government and private funding for biomedical research – Substantial investments in life sciences research are accelerating the adoption of mice models in academic and commercial laboratories.

Market Challenges

1. Ethical concerns and regulatory constraints – Animal testing is subject to stringent regulations and ethical scrutiny, which can limit the scope of research and increase compliance costs.
2. High cost of specialized mice models – Genetically engineered or disease-specific models are expensive to produce and maintain, posing challenges for small research institutions.
3. Limited availability of certain strains – Some highly specialized mice models may have restricted availability, affecting experimental timelines and scalability.
4. Technological complexity – Generating and maintaining genetically modified mice requires advanced technical expertise and infrastructure, which may not be readily accessible in all regions.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/mice-model-market 

Regional Analysis
North America dominates the mice model market, driven by a strong presence of leading pharmaceutical and biotechnology companies, well-established research infrastructure, and significant funding for preclinical studies. The U.S. is a key contributor due to its robust life sciences ecosystem and regulatory frameworks that support research innovation.

Europe is another major market, with countries like Germany, the U.K., and France investing heavily in biomedical research and preclinical studies. The region has strong adoption of advanced mice models, including transgenic and knockout strains.

Asia-Pacific is witnessing rapid growth, propelled by increasing investments in pharmaceutical R&D, expanding biotechnology sectors, and growing academic research initiatives in countries such as China, Japan, and India. Latin America and the Middle East & Africa are emerging markets, driven by the expansion of research infrastructure and rising focus on regional biomedical advancements.

Key Companies

• Charles River Laboratories International, Inc.
• Envigo RMS, LLC
• Taconic Biosciences, Inc.
• The Jackson Laboratory
• Oriental BioService, Inc.
• Shanghai Model Organisms Center, Inc.
• GemPharmatech Co., Ltd.
• Beijing Vital River Laboratory Animal Technology Co., Ltd.
• CrownBio
• Janvier Labs

Conclusion
The mice model market is poised for continued growth as the demand for preclinical research, drug discovery, and genetic studies intensifies globally. Technological advancements in genetic engineering, increasing prevalence of chronic diseases, and substantial research funding are key factors driving market adoption. Despite challenges such as ethical concerns, high costs, and technical complexities, mice models remain indispensable for biomedical research.

More Trending Latest Reports By Polaris Market Research:

Healthy Snacks Market

Botanical Supplements Market

Xylitol Market

Machine Tools Market

Botanical Supplements Market

Organic Personal Care Market

X-ray Irradiation Market

Dental Equipment Market

Spices And Seasonings Market

Infection Surveillance Solutions Market

Lactase Market

Polypropylene Market

Infection Surveillance Solutions Market

Aerogel Market

U.S. X-ray Irradiation Market

Dental Equipment Market